高海拔地区创伤性脑损伤患者PaCO2与预后的关联:一项前瞻性单中心队列研究
这项前瞻性单中心队列研究纳入海拔2600米创伤中心连续收治的81例创伤性脑损伤(TBI)患者,随访6个月,不良结局定义为GOSE评分<4。不良结局发生率为30%(25/81),6个月死亡率为24%(20/81)。多因素分析显示年龄(OR 1.14)、头部简明损伤评分(OR 4.7)和PaCO2水平(OR 1.23)与不良结局显著相关;在机械通气亚组中,头部简明损伤评分(OR 5.4)和PaCO2水平(OR 1.36)仍与不良结局显著相关。作者认为,较高的PaCO2水平与机械通气TBI患者的不良结局相关,并提示需要考虑是否应针对高海拔人群调整PaCO2目标。
要点
- 高海拔(2600米)TBI患者中,不良结局(6个月GOSE<4)发生率为30%(25/81),6个月死亡率为24%(20/81)。
- 不良结局组PaCO2均值35±8 mmHg,高于良好结局组的32±6 mmHg(P<0.01)。
- 多因素分析:PaCO2每升高一个单位,不良结局风险增加(OR 1.23,95%CI 1.10-1.53,P<0.05)。
- 机械通气亚组中PaCO2与不良结局的关联仍显著(OR 1.36,95%CI 1.13-1.78,P=0.015)。
- 作者认为,较高的PaCO2水平与机械通气TBI患者的不良结局相关,并提示需考虑是否应针对高海拔人群调整PaCO2目标。
适用人群与场景
- 海拔2600米创伤中心连续收治的创伤性脑损伤(TBI)患者,共81例有完整数据。
- 入院GCS中位数9(6-14)分;重度TBI(GCS 3-8)占49%(40/81),中度TBI(GCS 12-9)占32%(26/81),轻度TBI(GCS 13-15)占18%(15/81)。
- 男性占80%(65/81),年龄中位数36(25-50)岁,头部简明损伤评分(AISh)中位数3(2-4)。
诊断标准与关键阈值
- 不良结局定义:6个月随访时格拉斯哥结局扩展量表(GOSE)评分<4。
研究设计与关键结果
- 研究类型:前瞻性单中心队列研究,纳入海拔2600米创伤中心连续收治的81例TBI患者。
- 主要终点:6个月不良结局(GOSE<4)发生率为30%(25/81),GOSE中位数4(2-5),6个月死亡率为24%(20/81)。
- 不良结局组与良好结局组比较:年龄中位数49(30-72)岁 vs 29(22-41)岁,P<0.01;入院GCS 6(4-8)分 vs 13(8-15)分,P<0.01;AISh 4(4-4) vs 3(2-4),P<0.01;急性生理与慢性健康评分II(APACHE II)17(15-23) vs 10(6-14),P<0.01;Charlson评分0(0-2) vs 0(0-0),P<0.01;PaCO2均值35±8 mmHg vs 32±6 mmHg,P<0.01。
- 多因素分析:年龄(OR 1.14,95%CI 1.1-1.30,P<0.01)、AISh(OR 4.7,95%CI 1.55-21.0,P<0.05)、PaCO2水平(OR 1.23,95%CI 1.10-1.53,P<0.05)与不良结局显著相关。
- 机械通气亚组多因素分析:AISh(OR 5.4,95%CI 1.61-28.5,P=0.017)和PaCO2水平(OR 1.36,95%CI 1.13-1.78,P=0.015)仍与不良结局显著相关。
证据类型、等级与局限
- 证据类型:前瞻性单中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,较高的PaCO2水平与机械通气TBI患者的不良结局相关;这些结果强调了PaCO2水平在TBI患者中的重要性,并提示需考虑是否应针对高海拔人群调整PaCO2目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Partial pressure of carbon dioxide (PaCO2) is generally known to influence outcome in patients with traumatic brain injury (TBI) at normal altitudes. Less is known about specific relationships of PaCO2 levels and clinical outcomes at high altitudes.
METHODS: This is a prospective single-center cohort of consecutive patients with TBI admitted to a trauma center located at 2600 m above sea level. An unfavorable outcome was defined as a Glasgow Outcome Scale-Extended (GOSE) score < 4 at the 6-month follow-up.
RESULTS: We had a total of 81 patients with complete data, 80% (65/81) were men, and the median (interquartile range) age was 36 (25-50) years. Median Glasgow Coma Scale (GCS) score on admission was 9 (6-14); 49% (40/81) of patients had severe TBI (GCS 3-8), 32% (26/81) had moderate TBI (GCS 12-9), and 18% (15/81) had mild TBI (GCS 13-15). The median (interquartile range) Abbreviated Injury Score of the head (AISh) was 3 (2-4). The frequency of an unfavorable outcome (GOSE < 4) was 30% (25/81), the median GOSE was 4 (2-5), and the median 6-month mortality rate was 24% (20/81). Comparison between patients with favorable and unfavorable outcomes revealed that those with unfavorable outcome were older, (median age 49 [30-72] vs. 29 [22-41] years, P < 0.01), had lower admission GCS scores (6 [4-8] vs. 13 [8-15], P < 0.01), had higher AISh scores (4 [4-4] vs. 3 [2-4], P < 0.01), had higher Acute Physiology and Chronic Health disease Classification System II scores (17 [15-23] vs. 10 [6-14], P < 0.01), had higher Charlson scores (0 [0-2] vs. 0 [0-0], P < 0.01), and had higher PaCO2 levels (mean 35 ± 8 vs. 32 ± 6 mm Hg, P < 0.01). In a multivariate analysis, age (odds ratio [OR] 1.14, 95% confidence interval [CI] 1.1-1.30, P < 0.01), AISh (OR 4.7, 95% CI 1.55-21.0, P < 0.05), and PaCO2 levels (OR 1.23, 95% CI 1.10-1.53, P < 0.05) were significantly associated with the unfavorable outcomes. When applying the same analysis to the subgroup on mechanical ventilation, AISh (OR 5.4, 95% CI 1.61-28.5, P = 0.017) and PaCO2 levels (OR 1.36, 95% CI 1.13-1.78, P = 0.015) remained significantly associated with the unfavorable outcome.
CONCLUSIONS: Higher PaCO2 levels are associated with an unfavorable outcome in ventilated patients with TBI. These results underscore the importance of PaCO2 levels in patients with TBI and whether it should be adjusted for populations living at higher altitudes.
参考来源
- Cáceres E, Divani AA, Rubinos CA, et al. PaCO2 Association with Outcomes of Patients with Traumatic Brain Injury at High Altitude: A Prospective Single-Center Cohort Study. Neurocrit Care. 2024. PMID: 38740704. doi:10.1007/s12028-024-01982-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。